Brincidofovir

Brincidofovir (CMX001) is an experimental antiviral drug being developed by Chimerix for the treatment of cytomegalovirus. It also has activity against adenoviruses, BK virus and herpes simplex viruses.

Brincidofovir is a prodrug of cidofovir.